Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

CU Study Suggests Link Between Tumor Suppressors and Starvation Survival

Published: Tuesday, May 14, 2013
Last Updated: Tuesday, May 14, 2013
Bookmark and Share
A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division, it also can help make cells more fit by allowing them to fend off stress.

CU-Boulder Professor Min Han said the research team was interested in how a common tumor suppressor gene known as Retinoblastoma 1, or Rb, behaved under conditions of starvation. The question is important, said Han, because it may help researchers understand why many cancer cells are more susceptible to starvation or fasting than ordinary cells.

Han and his team studied a popular lab organism called C. elegans, a translucent nematode smaller than an eyelash. Many of the C. elegans genes have similar, corresponding human genes called homologs, and almost all cellular mechanisms found in the nematodes also are found in mammals, including humans, he said.  The team charted changes in the physiology of newly hatched C. elegans in the absence of food to look at the corresponding stress response.

“We found the tumor suppressor Rb is a critical regulator of the starvation response,” said Han, who also is a Howard Hughes Medical Investigator. “Rb is known for doing more than just suppressing cell division associated with cancer -- it carries out a host of other cellular tasks including regulating development.  The new findings by our group and research by other groups suggest organisms survive longer when they encounter starvation by regulating the expression of a large number of genes.”

A paper on the subject was published online May 9 in Current Biology, a publication of Cell Press. The co-authors on the study, Mingxue Cui, Max Cohen and Cindy Teng, are all researchers associated with both CU-Boulder and HHMI. The study was funded by HHMI and the National Institutes of Health.

As part of the study, the researchers monitored the two- to three-week survival time of hundreds of C. elegans hatchlings in an environment with no food, which caused immediate “developmental arrest,” said Han, a professor in CU-Boulder’s molecular, cellular and developmental biology department. “The survival time of the young nematodes is dramatically shorter when the Rb gene is mutated, which causes changes in the activities of multiple cell signaling pathways.”

The study suggests that Rb plays a critical role in maintaining a starvation-induced “transcriptome,” which is the transcription of DNA to corresponding bits of RNA that allow researchers to pinpoint when and where each gene is turned on or off in the cells, he said. Under starved conditions, for example, Rb represses some responses induced by other physical stressors like pathogens and toxins.

Han said the Rb gene is mutated in a large percentage of human cancers. Hundreds of mutations in the RB gene have been identified in people with retinoblastoma, a rare type of eye cancer that usually strikes young children.

“Altogether, these findings identify Rb as a critical regulator of the starvation response and suggest a link between functions of tumor suppressors and starvation survival,” the team wrote in Current Biology. “These results may provide mechanistic insights into why cancer cells are often hypersensitive to starvation treatment.”

There are about 330 HHMI Investigators in the nation, including 15 Nobel laureates and 157 members of the National Academy of Sciences.  Other HHMI Investigators at CU-Boulder include Natalie Ahn, Kristi Anseth, Tom Cech (also a Nobel laureate) and Roy Parker. In addition, HHMI Investigator Lee Niswander is at the University of Colorado Denver School of Medicine.

Founded in 1953 by aviator and industrialist Howard R. Hughes, HHMI is a nonprofit medical research organization that ranks as one of the nation’s largest philanthropies.  In 2012 HHMI spent $800 million for research and $119 million for science education.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Next-Gen Melanoma Drug Excels in Lab Tests
Anti-cancer activity was reported in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733.
Thursday, November 13, 2014
Serendipity Points to New Potential Target and Therapy for Melanoma
A University of Colorado Cancer Center describes a new target and potential treatment for melanoma, the most dangerous form of skin cancer.
Friday, December 21, 2012
Scientific News
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
A New Single-Molecule Tool to Observe Enzymes at Work
A team of scientists at the University of Washington and the biotechnology company Illumina have created an innovative tool to directly detect the delicate, single-molecule interactions between DNA and enzymatic proteins.
Milestone Single-Biomolecule Imaging Technique May Advance Drug Design
The first nanometer resolved image of individual tobacco mosaic virions shows the potential of low-energy electron holography for imaging biomolecules at a single particle level; a milestone in structural biology and a potential new tool for drug design.
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos